4CYTE Equine, now available from Henry Schein, is available for use to maintain joint health in horses, before and after surgery, for horses prone to joint conditions. Produced by Interpath Pty, Ltd., 4CYTE Equine has been extensively studied in clinical trials and was developed to address joint health in horses. 4CYTE Equine’s key ingredient Epiitalis is patented for its ability to proliferate chondrocyte cells for cartilage regeneration. 4CYTE Equine pellets are sold in (two size packages).
For additional information contact Henry Schein Animal Health at 1-800-872-4346, (8 am – 8 pm ET), or visit www.henryscheinvet.com.
Henry Schein Animal Health, based in Dublin, Ohio, is the leading companion animal health distribution company in the United States. The Company employs approximately 900 team members, including 300 field sales representatives and 200 telesales and customer support representatives. With 14 strategically located, state-of-the-art distribution facilities and 10 inside sales centers, the Company maintains more than a 99 percent order-fill ratio, accomplishing its mission of providing the right product at the right place and at the right time. Partnering with over 400 leading animal health manufacturers in the world, Henry Schein Animal Health is positioned to offer the broadest selection of veterinary products and strategic solutions to companion animal, equine, and large animal practices. For more information, visit www.henryscheinvet.com.
